换一批Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
第一作者：
Michal,Jarzab
第一单位：
3rd Department of Radiotherapy and Chemotherapy, Breast Cancer Center, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. mjarzab@io.gliwice.pl.
作者：
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);CDC2蛋白激酶(CDC2 Protein Kinase);队列研究(Cohort Studies);细胞周期蛋白质依赖激酶类(Cyclin-Dependent Kinases);女(雌)性(Female);HSP90热休克蛋白质类(HSP90 Heat-Shock Proteins);人类(Humans);免疫组织化学(Immunohistochemistry);Ki-67抗原(Ki-67 Antigen);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤分期(Neoplasm Staging);治疗结果(Treatment Outcome)
DOI
10.5603/FHC.a2016.0026
PMID
28051275
发布时间
2017-11-16
- 浏览35
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
